No further COO sales under 10b5-1 plan
Company: Nebius
The claim, verbatim
The sales represented about 17% of Nave's granted equity, and no further sales will be made under the May 22, 2026 Rule 10b5-1 trading plan.
Source (primary)
A COO sells approximately 17% of his granted equity in Nebius Group (NBIS) under a trading plan. - Stock Titan (-, news_article)
View cached copy (2026-10-07)Live source ↗Archive.org ↗
Quote: “represented approximately 17% of his granted equity, and no further sales will be made under that plan”
How we checked this
Checked on October 9, 2026. The cited source supports every part of this claim.
The Form 4 remarks state that the sales were under a Rule 10b5-1 plan adopted May 22, 2026. They also say the shares sold were about 17% of Nave's granted equity and that no further sales will be made under that plan.
Confirmed in the source:
- The shares sold represented approximately 17% of Nave's granted equity in Nebius
- No further sales will be made under the trading plan
- The trading plan was a Rule 10b5-1 plan adopted May 22, 2026
What we did: Read our cached copy of the publisher (https://www.stocktitan.net/sec-filings/NBIS/form-4-nebius-group-n-v-insider-trading-activity-5987e147cb8b.html) in full (24,226 characters, retrieved October 7, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms A COO sells approximately 17% of his granted equity in Nebius Group (NBIS) under a trading plan. - Stock Titan
Quote: “represented approximately 17% of his granted equity, and no further sales will be made under that plan”